Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 565

Similar articles for PubMed (Select 19190809)

1.

Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.

Licht C, Fremeaux-Bacchi V.

Thromb Haemost. 2009 Feb;101(2):271-8. Review.

PMID:
19190809
2.

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.

Servais A, Noël LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grünfeld JP, Niaudet P, Lesavre P, Frémeaux-Bacchi V.

Kidney Int. 2012 Aug;82(4):454-64. doi: 10.1038/ki.2012.63. Epub 2012 Mar 28.

PMID:
22456601
3.

Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation.

Leroy V, Fremeaux-Bacchi V, Peuchmaur M, Baudouin V, Deschênes G, Macher MA, Loirat C.

Pediatr Nephrol. 2011 Mar;26(3):419-24. doi: 10.1007/s00467-010-1734-4. Epub 2010 Dec 25.

PMID:
21188423
4.

Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.

Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F.

J Med Genet. 2007 Mar;44(3):193-9. Epub 2006 Oct 3.

5.

MPGN II--genetically determined by defective complement regulation?

Licht C, Schlötzer-Schrehardt U, Kirschfink M, Zipfel PF, Hoppe B.

Pediatr Nephrol. 2007 Jan;22(1):2-9. Epub 2006 Sep 23.

PMID:
17024390
8.

Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.

Sethi S, Fervenza FC, Zhang Y, Nasr SH, Leung N, Vrana J, Cramer C, Nester CM, Smith RJ.

Clin J Am Soc Nephrol. 2011 May;6(5):1009-17. doi: 10.2215/CJN.07110810. Epub 2011 Mar 17.

9.

In situ complement activation in porcine membranoproliferative glomerulonephritis type II.

Jansen JH, Høgåsen K, Harboe M, Hovig T.

Kidney Int. 1998 Feb;53(2):331-49.

10.

Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification.

Sethi S, Fervenza FC.

Semin Nephrol. 2011 Jul;31(4):341-8. doi: 10.1016/j.semnephrol.2011.06.005. Review.

PMID:
21839367
11.

Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.

Schena FP, Pertosa G, Stanziale P, Vox E, Pecoraro C, Andreucci VE.

Clin Nephrol. 1982 Nov;18(5):240-6.

PMID:
7151338
12.

Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.

Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, Walport MJ, Botto M.

Nat Genet. 2002 Aug;31(4):424-8. Epub 2002 Jul 1.

PMID:
12091909
13.

Experimental models of membranoproliferative glomerulonephritis, including dense deposit disease.

Vernon KA, Pickering MC, Cook T.

Contrib Nephrol. 2011;169:198-210. doi: 10.1159/000314775. Epub 2011 Jan 20.

PMID:
21252520
14.

Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.

Skerka C, Licht C, Mengel M, Uzonyi B, Strobel S, Zipfel PF, Józsi M.

Mol Immunol. 2009 Sep;46(14):2801-7. doi: 10.1016/j.molimm.2009.05.018. Epub 2009 Jul 28. Review.

PMID:
19640589
15.

Autoantibody to complement neoantigens in membranoproliferative glomerulonephritis.

Strife CF, Prada AL, Clardy CW, Jackson E, Forristal J.

J Pediatr. 1990 May;116(5):S98-102.

PMID:
2329415
16.
17.

Pathogenesis of the C3 glomerulopathies and reclassification of MPGN.

Bomback AS, Appel GB.

Nat Rev Nephrol. 2012 Nov;8(11):634-42. doi: 10.1038/nrneph.2012.213. Epub 2012 Oct 2. Review.

PMID:
23026947
18.

Management of membranoproliferative glomerulonephritis type II with plasmapheresis.

Kurtz KA, Schlueter AJ.

J Clin Apher. 2002;17(3):135-7.

PMID:
12378549
19.

Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.

Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, Kirschfink M, Lambris JD, Lanning L, Lutz HU, Meri S, Rose NR, Salant DJ, Sethi S, Smith RJ, Smoyer W, Tully HF, Tully SP, Walker P, Welsh M, Würzner R, Zipfel PF.

J Am Soc Nephrol. 2005 May;16(5):1392-403. Epub 2005 Mar 30. Review.

20.

Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF.

Tanuma Y, Ohi H, Hatano M.

Clin Immunol Immunopathol. 1990 Aug;56(2):226-38.

PMID:
2143128
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk